Evaluation of the Prognostic and Predictive Value of HER-1/EGFR in Breast Cancer Patients Participating in a Randomized Study with Dose-Dense Sequential Adjuvant Chemotherapy-Reference-Cited by-同舟云学术

Evaluation of the Prognostic and Predictive Value of HER-1/EGFR in Breast Cancer Patients Participating in a Randomized Study with Dose-Dense Sequential Adjuvant Chemotherapy

Published:2007 Issue:5-6 Volume:72 Page:388-396
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Tzaida Olympia,Gogas Helen,Dafni Urania,Kyroudi Aspasia,Papaspyrou Irene,Kyriakou Vasiliki,Malamou-Mitsi Vasiliki,Alamani Maria,Skopa Chrisoula,Kostopoulos Ioannis,Kastritis Efstathios,Pectasides Dimitrios,Briasoulis Evangelos,Kalofonos Haralabos P.,Aravantinos Gerasimos,Fountzilas George,Arapantoni-Dadioti Petroula

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference46 articles.

1. Polychemotherapy for early breast cancer: an overview of the randomised trials

2. Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers

3. Gusterson BA: The changing role of the pathologist in the prediction of tumor behaviour and response to treatment; in Dickson RB, Lippman ME (eds): Drug and Hormonal Resistance in Breast Cancer. New York, Horwood, 1995, pp 39-53.

4. The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer

5. Epidermal growth factor receptors: critical mediators of multiple receptor pathways

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy;Frontiers in Oncology;2024-01-10

2. Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study;PLOS ONE;2018-12-06

3. Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis;Cancer Treatment Reviews;2018-01

4. Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer;Clinical Cancer Research;2016-04-22

5. Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline;Journal of Clinical Oncology;2016-04-01